Clinical trial

Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral…

NCT00426595 · University Hospital, Ghent, Other · Completed

Key facts

NCT number NCT00426595
Title Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation
Official title Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation
Lead sponsor University Hospital, Ghent, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Gastreoesophageal Reflux Disease
Intervention type Drug
Interventions Administration of omeprazole suspension, omeprazole administered as a multi-unit-pellet system
Enrollment 14
Start date Apr 1, 2007
Primary completion Nov 1, 2007
Completion Nov 1, 2007
First posted Jan 25, 2007
Last update posted Apr 10, 2009
Countries Belgium

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies